Rennova Health (NASDAQ:RNVA)- Stocks Ensnare on Profitability Ratio: Quantum (NYSE:QTM)

By tracking previous views Rennova Health, Inc. (NASDAQ:RNVA) also in plain sight to attract passive investors, shares in most recent trading session knocking up -11.87% after traded at $0.13. For trailing twelve months, RNVA attains gross profit margin of 54.50%, that are showing consistency of trends in firm’s earnings. While to figure out more clear vision, firm’s returns on investment calculated as -334.80%; it gives answer about efficiency of different investments in different securities.

The firm has noticeable volatility credentials, price volatility of stock was 61.25% for a week and 32.19% for a month. The performance of firm for the quarter recorded as -37.50% and for year stands at -92.65%, while the YTD performance was -88.89%. The co attains 0.04 for Average True Range for 14 days. The stock price of RNVA is moving up from its 20 days moving average with 20.33% and isolated positively from 50 days moving average with 0.92%.

Quantum Corporation (NYSE:QTM) persists its position slightly strong in context of buying side, while shares price are surging -1.51% during latest trading session.

Profitability Ratio Analysis; to measure firm’s performance and profitability, we focus on ordinary profitability ratio, QTM has gross profit margin of 43.50% for trailing twelve months and operating margin is calculated as -9.10%, these are a better detectors to find consistency or positive/negative trends in a firm’s earnings. Following in trace line, returns on investment amplify the findings, the firm’s ROI concludes as -835.50%; it gives idea for personal financial decisions, to compare a firm’s profitability or to compare the efficiency of different investments. The returns on assets of firm also on noticeable level, it has ROA of -22.50%, which signifies how profitable a firm is relative to its total assets.

To make strengthen this views, the active industry firm has Quick Ratio of 0.80, which indicates firm has sufficient short-term assets to cover its immediate liabilities. Taking notice on volatility measures, price volatility of stock was 6.12% for a week and 5.34% for a month.


About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Reply

Your email address will not be published. Required fields are marked *